Gage-Brown, A.; George, C.; Maleki, J.; Singh, K.P.; Muhi, S.
Is Piperacillin-Tazobactam an Appropriate Empirical Agent for Hospital-Acquired Sepsis and Community-Acquired Septic Shock of Unknown Origin in Australia? Healthcare 2022, 10, 851.
https://doi.org/10.3390/healthcare10050851
AMA Style
Gage-Brown A, George C, Maleki J, Singh KP, Muhi S.
Is Piperacillin-Tazobactam an Appropriate Empirical Agent for Hospital-Acquired Sepsis and Community-Acquired Septic Shock of Unknown Origin in Australia? Healthcare. 2022; 10(5):851.
https://doi.org/10.3390/healthcare10050851
Chicago/Turabian Style
Gage-Brown, Alice, Catherine George, Jenna Maleki, Kasha P. Singh, and Stephen Muhi.
2022. "Is Piperacillin-Tazobactam an Appropriate Empirical Agent for Hospital-Acquired Sepsis and Community-Acquired Septic Shock of Unknown Origin in Australia?" Healthcare 10, no. 5: 851.
https://doi.org/10.3390/healthcare10050851
APA Style
Gage-Brown, A., George, C., Maleki, J., Singh, K. P., & Muhi, S.
(2022). Is Piperacillin-Tazobactam an Appropriate Empirical Agent for Hospital-Acquired Sepsis and Community-Acquired Septic Shock of Unknown Origin in Australia? Healthcare, 10(5), 851.
https://doi.org/10.3390/healthcare10050851